APOBEC3G cytidine deaminase association with coronavirus nucleocapsid protein.
Identifieur interne : 001952 ( PubMed/Checkpoint ); précédent : 001951; suivant : 001953APOBEC3G cytidine deaminase association with coronavirus nucleocapsid protein.
Auteurs : Shui-Mei Wang [Taïwan] ; Chin-Tien WangSource :
- Virology [ 1096-0341 ] ; 2009.
Descripteurs français
- KwdFr :
- APOBEC-3G Deaminase, Cartographie peptidique, Cytidine deaminase (métabolisme), Humains, Liaison aux protéines, Lignée cellulaire, Protéine de capside p24 du VIH (métabolisme), Protéines de fusion recombinantes, Protéines nucléocapside (métabolisme), Régulation de l'expression des gènes viraux (physiologie), Virus du SRAS (métabolisme).
- MESH :
English descriptors
- KwdEn :
- MESH :
- chemical , metabolism : Cytidine Deaminase, HIV Core Protein p24, Nucleocapsid Proteins.
- chemical : APOBEC-3G Deaminase, Recombinant Fusion Proteins.
- metabolism : SARS Virus.
- physiology : Gene Expression Regulation, Viral.
- Cell Line, Humans, Peptide Mapping, Protein Binding.
Abstract
We previously reported that replacing HIV-1 nucleocapsid (NC) domain with SARS-CoV nucleocapsid (N) residues 2-213, 215-421, or 234-421 results in efficient virus-like particle (VLP) production at a level comparable to that of wild-type HIV-1. In this study we demonstrate that these chimeras are capable of packaging large amounts of human APOBEC3G (hA3G), and that an HIV-1 Gag chimera containing the carboxyl-terminal half of human coronavirus 229E (HCoV-229E) N as a substitute for NC is capable of directing VLP assembly and efficiently packaging hA3G. When co-expressed with SARS-CoV N and M (membrane) proteins, hA3G was efficiently incorporated into SARS-CoV VLPs. Data from GST pull-down assays suggest that the N sequence involved in N-hA3G interactions is located between residues 86 and 302. Like HIV-1 NC, the SARS-CoV or HCoV-229E N-associated with hA3G depends on the presence of RNA, with the first linker region essential for hA3G packaging into both HIV-1 and SARS-CoV VLPs. The results raise the possibility that hA3G is capable of associating with different species of viral structural proteins through a potentially common, RNA-mediated mechanism.
DOI: 10.1016/j.virol.2009.03.010
PubMed: 19345973
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:19345973Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">APOBEC3G cytidine deaminase association with coronavirus nucleocapsid protein.</title>
<author><name sortKey="Wang, Shui Mei" sort="Wang, Shui Mei" uniqKey="Wang S" first="Shui-Mei" last="Wang">Shui-Mei Wang</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medical Research and Education, Taipei Veterans General Hospital, Taipei, Taiwan.</nlm:affiliation>
<country xml:lang="fr">Taïwan</country>
<wicri:regionArea>Department of Medical Research and Education, Taipei Veterans General Hospital, Taipei</wicri:regionArea>
<wicri:noRegion>Taipei</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wang, Chin Tien" sort="Wang, Chin Tien" uniqKey="Wang C" first="Chin-Tien" last="Wang">Chin-Tien Wang</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2009">2009</date>
<idno type="RBID">pubmed:19345973</idno>
<idno type="pmid">19345973</idno>
<idno type="doi">10.1016/j.virol.2009.03.010</idno>
<idno type="wicri:Area/PubMed/Corpus">001932</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001932</idno>
<idno type="wicri:Area/PubMed/Curation">001932</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001932</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001952</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001952</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">APOBEC3G cytidine deaminase association with coronavirus nucleocapsid protein.</title>
<author><name sortKey="Wang, Shui Mei" sort="Wang, Shui Mei" uniqKey="Wang S" first="Shui-Mei" last="Wang">Shui-Mei Wang</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medical Research and Education, Taipei Veterans General Hospital, Taipei, Taiwan.</nlm:affiliation>
<country xml:lang="fr">Taïwan</country>
<wicri:regionArea>Department of Medical Research and Education, Taipei Veterans General Hospital, Taipei</wicri:regionArea>
<wicri:noRegion>Taipei</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wang, Chin Tien" sort="Wang, Chin Tien" uniqKey="Wang C" first="Chin-Tien" last="Wang">Chin-Tien Wang</name>
</author>
</analytic>
<series><title level="j">Virology</title>
<idno type="eISSN">1096-0341</idno>
<imprint><date when="2009" type="published">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>APOBEC-3G Deaminase</term>
<term>Cell Line</term>
<term>Cytidine Deaminase (metabolism)</term>
<term>Gene Expression Regulation, Viral (physiology)</term>
<term>HIV Core Protein p24 (metabolism)</term>
<term>Humans</term>
<term>Nucleocapsid Proteins (metabolism)</term>
<term>Peptide Mapping</term>
<term>Protein Binding</term>
<term>Recombinant Fusion Proteins</term>
<term>SARS Virus (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>APOBEC-3G Deaminase</term>
<term>Cartographie peptidique</term>
<term>Cytidine deaminase (métabolisme)</term>
<term>Humains</term>
<term>Liaison aux protéines</term>
<term>Lignée cellulaire</term>
<term>Protéine de capside p24 du VIH (métabolisme)</term>
<term>Protéines de fusion recombinantes</term>
<term>Protéines nucléocapside (métabolisme)</term>
<term>Régulation de l'expression des gènes viraux (physiologie)</term>
<term>Virus du SRAS (métabolisme)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Cytidine Deaminase</term>
<term>HIV Core Protein p24</term>
<term>Nucleocapsid Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>APOBEC-3G Deaminase</term>
<term>Recombinant Fusion Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Cytidine deaminase</term>
<term>Protéine de capside p24 du VIH</term>
<term>Protéines nucléocapside</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Régulation de l'expression des gènes viraux</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Gene Expression Regulation, Viral</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Cell Line</term>
<term>Humans</term>
<term>Peptide Mapping</term>
<term>Protein Binding</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>APOBEC-3G Deaminase</term>
<term>Cartographie peptidique</term>
<term>Humains</term>
<term>Liaison aux protéines</term>
<term>Lignée cellulaire</term>
<term>Protéines de fusion recombinantes</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We previously reported that replacing HIV-1 nucleocapsid (NC) domain with SARS-CoV nucleocapsid (N) residues 2-213, 215-421, or 234-421 results in efficient virus-like particle (VLP) production at a level comparable to that of wild-type HIV-1. In this study we demonstrate that these chimeras are capable of packaging large amounts of human APOBEC3G (hA3G), and that an HIV-1 Gag chimera containing the carboxyl-terminal half of human coronavirus 229E (HCoV-229E) N as a substitute for NC is capable of directing VLP assembly and efficiently packaging hA3G. When co-expressed with SARS-CoV N and M (membrane) proteins, hA3G was efficiently incorporated into SARS-CoV VLPs. Data from GST pull-down assays suggest that the N sequence involved in N-hA3G interactions is located between residues 86 and 302. Like HIV-1 NC, the SARS-CoV or HCoV-229E N-associated with hA3G depends on the presence of RNA, with the first linker region essential for hA3G packaging into both HIV-1 and SARS-CoV VLPs. The results raise the possibility that hA3G is capable of associating with different species of viral structural proteins through a potentially common, RNA-mediated mechanism.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19345973</PMID>
<DateCompleted><Year>2009</Year>
<Month>05</Month>
<Day>21</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>01</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-0341</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>388</Volume>
<Issue>1</Issue>
<PubDate><Year>2009</Year>
<Month>May</Month>
<Day>25</Day>
</PubDate>
</JournalIssue>
<Title>Virology</Title>
<ISOAbbreviation>Virology</ISOAbbreviation>
</Journal>
<ArticleTitle>APOBEC3G cytidine deaminase association with coronavirus nucleocapsid protein.</ArticleTitle>
<Pagination><MedlinePgn>112-20</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.virol.2009.03.010</ELocationID>
<Abstract><AbstractText>We previously reported that replacing HIV-1 nucleocapsid (NC) domain with SARS-CoV nucleocapsid (N) residues 2-213, 215-421, or 234-421 results in efficient virus-like particle (VLP) production at a level comparable to that of wild-type HIV-1. In this study we demonstrate that these chimeras are capable of packaging large amounts of human APOBEC3G (hA3G), and that an HIV-1 Gag chimera containing the carboxyl-terminal half of human coronavirus 229E (HCoV-229E) N as a substitute for NC is capable of directing VLP assembly and efficiently packaging hA3G. When co-expressed with SARS-CoV N and M (membrane) proteins, hA3G was efficiently incorporated into SARS-CoV VLPs. Data from GST pull-down assays suggest that the N sequence involved in N-hA3G interactions is located between residues 86 and 302. Like HIV-1 NC, the SARS-CoV or HCoV-229E N-associated with hA3G depends on the presence of RNA, with the first linker region essential for hA3G packaging into both HIV-1 and SARS-CoV VLPs. The results raise the possibility that hA3G is capable of associating with different species of viral structural proteins through a potentially common, RNA-mediated mechanism.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName>
<ForeName>Shui-Mei</ForeName>
<Initials>SM</Initials>
<AffiliationInfo><Affiliation>Department of Medical Research and Education, Taipei Veterans General Hospital, Taipei, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wang</LastName>
<ForeName>Chin-Tien</ForeName>
<Initials>CT</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2009</Year>
<Month>04</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Virology</MedlineTA>
<NlmUniqueID>0110674</NlmUniqueID>
<ISSNLinking>0042-6822</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016655">HIV Core Protein p24</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019590">Nucleocapsid Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011993">Recombinant Fusion Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C099602">nucleocapsid protein, Coronavirus</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.5.4.5</RegistryNumber>
<NameOfSubstance UI="D000071480">APOBEC-3G Deaminase</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.5.4.5</RegistryNumber>
<NameOfSubstance UI="C464924">APOBEC3G protein, human</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.5.4.5</RegistryNumber>
<NameOfSubstance UI="D003564">Cytidine Deaminase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000071480" MajorTopicYN="N">APOBEC-3G Deaminase</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003564" MajorTopicYN="N">Cytidine Deaminase</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015967" MajorTopicYN="N">Gene Expression Regulation, Viral</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016655" MajorTopicYN="N">HIV Core Protein p24</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019590" MajorTopicYN="N">Nucleocapsid Proteins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010449" MajorTopicYN="N">Peptide Mapping</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011993" MajorTopicYN="N">Recombinant Fusion Proteins</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2008</Year>
<Month>12</Month>
<Day>02</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2009</Year>
<Month>01</Month>
<Day>09</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2009</Year>
<Month>03</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2009</Year>
<Month>4</Month>
<Day>7</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2009</Year>
<Month>4</Month>
<Day>7</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2009</Year>
<Month>5</Month>
<Day>22</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">19345973</ArticleId>
<ArticleId IdType="pii">S0042-6822(09)00183-4</ArticleId>
<ArticleId IdType="doi">10.1016/j.virol.2009.03.010</ArticleId>
<ArticleId IdType="pmc">PMC7103413</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Biochem Biophys Res Commun. 2004 May 14;317(4):1030-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15094372</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochemistry. 2006 Oct 3;45(39):11827-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17002283</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2005 Nov;79(22):13848-55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16254320</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2007 Dec;81(23):13112-24</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17881443</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2007 Apr;81(8):3807-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17267497</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proteomics. 2005 Mar;5(4):925-37</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15759315</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Biol Chem. 2004 Aug 6;279(32):33177-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15159405</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2004 Jul 30;305(5684):645</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15286366</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Struct Mol Biol. 2004 May;11(5):435-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15098018</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>FEBS Lett. 2007 Oct 2;581(24):4761-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17869248</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>RNA. 2008 Jun;14(6):1228-36</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18456846</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 2002 Aug 8;418(6898):646-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12167863</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Mol Cell. 2003 Sep;12(3):591-601</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14527406</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1998 Mar;72(3):1782-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9499028</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Cell. 2003 Jun 13;113(6):803-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12809610</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Curr Biol. 2003 Nov 11;13(22):2009-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14614829</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2006 Feb;80(3):1067-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16414984</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1994 Feb;68(2):704-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8289374</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2004 Mar 19;303(5665):1829</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15031497</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1999 Oct;73(10):8527-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10482606</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virus Res. 2003 Dec;98(2):131-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14659560</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2004 Nov;78(21):11841-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15479826</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 2008 Aug 15;378(1):97-104</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18550141</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Biol Chem. 2004 Feb 27;279(9):7792-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14672928</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2005 Jun;79(11):6620-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15890900</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Med. 2003 Nov;9(11):1404-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14528300</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 2004 Oct 25;328(2):163-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15464836</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Biol Chem. 2004 Aug 20;279(34):35822-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15210704</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochem Biophys Res Commun. 2004 Apr 2;316(2):476-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15020242</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2915-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17299050</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Biol Chem. 2005 Jun 17;280(24):23280-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15849181</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Biol Chem. 2008 Mar 21;283(12):7320-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18165230</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1996 Oct;70(10):6607-16</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8794295</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2002 Nov;76(22):11177-85</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12388677</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 2003 Jul 3;424(6944):94-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12808465</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2000 Jun;74(12):5395-402</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10823843</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1993 Nov;67(11):6487-98</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8411352</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2000 Apr;74(7):3418-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10708461</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Biol Chem. 2004 Aug 13;279(33):34083-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15215254</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2005 May;79(9):5870-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15827203</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2004 Feb;78(4):2072-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14747572</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Mol Biol. 2007 May 11;368(4):1075-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17379242</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Hepatology. 2005 Aug;42(2):301-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16025511</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochemistry. 2004 May 25;43(20):6059-63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15147189</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1993 Dec;67(12):7190-200</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8230441</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2003 Nov 7;302(5647):1056-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14564014</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 1985 Jan 24-30;313(6000):277-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2578615</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 2005 Mar 15;333(2):374-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15721369</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Cell. 2003 Jul 11;114(1):21-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12859895</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1998 Oct;72(10):7950-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9733833</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Biomed Sci. 2008 Nov;15(6):719-29</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18592403</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1995 Oct;69(10):6445-56</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7666546</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2004 Nov;78(22):12557-65</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15507643</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2005 Nov;79(22):13839-47</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16254319</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2004 Nov;78(21):12058-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15479846</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 2003 Jul 3;424(6944):99-103</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12808466</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2003 Nov;77(21):11398-407</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14557625</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1998 Nov;72(11):9034-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9765448</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1997 Sep;71(9):6765-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9261401</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Med. 2003 Nov;9(11):1398-403</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14528301</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2005 Oct 28;310(5748):676-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16195424</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14008-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8943051</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Taïwan</li>
</country>
</list>
<tree><noCountry><name sortKey="Wang, Chin Tien" sort="Wang, Chin Tien" uniqKey="Wang C" first="Chin-Tien" last="Wang">Chin-Tien Wang</name>
</noCountry>
<country name="Taïwan"><noRegion><name sortKey="Wang, Shui Mei" sort="Wang, Shui Mei" uniqKey="Wang S" first="Shui-Mei" last="Wang">Shui-Mei Wang</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001952 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001952 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= PubMed |étape= Checkpoint |type= RBID |clé= pubmed:19345973 |texte= APOBEC3G cytidine deaminase association with coronavirus nucleocapsid protein. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:19345973" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
This area was generated with Dilib version V0.6.33. |